Carteolol (ophthalmic) vs Beta2-Agonists

Interacting Drugs
Carteolol (ophthalmic)
vs
Beta2-Agonists
Security Level
Moderate, Consider therapy modification
Mechanism
Beta2-Agonists: Beta-Blockers (Nonselective) may diminish the bronchodilatory effect of Beta2-Agonists.
Management
Consider therapy modification

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Carteolol (ophthalmic) vs Beta2-Agonists